SCHEMBL13780979

SCHEMBL13780979

CC(C)(C)c1ccc(N(c2ccc(C(C)(C)C)cc2)c2cccc(C(=O)c3cccc(C(=O)c4cccc(N(c5ccc(C(C)(C)C)cc5)c5ccc(C(C)(C)C)cc5)c4)c3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 1/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ SRD5A2 P31213 1/20 0.45
▸ KCNK9 Q9NPC2 1/20 0.43
▸ HDAC8 Q9BY41 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ATM Q13315 1/20 0.43
▸ RAB9A P51151 3/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ ACHE P22303 3/20 0.41
▸ KCNK3 O14649 1/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13780980 0.82 TDP1 (0.47) MEN1KMT2ASRD5A2TDP1L3MBTL1
SCHEMBL13781015 0.80 LMNA (0.47) MEN1KMT2ASRD5A2TDP1L3MBTL1
SCHEMBL27828940 0.79 L3MBTL1 (0.61) MEN1KMT2ASMN1; SMN2SRD5A2TDP1
SCHEMBL13780986 0.79 L3MBTL1 (0.53) MEN1KMT2ASRD5A2TDP1L3MBTL1
SCHEMBL13780985 0.78 L3MBTL1 (0.43) MEN1KMT2ASMN1; SMN2TDP1L3MBTL1
SCHEMBL3916584 0.78 RAB9A (0.49) SIRT1MEN1KMT2ASMN1; SMN2SRD5A2
SCHEMBL14163856 0.78 CYP2D6 (0.44) MEN1KMT2ASMN1; SMN2KCNK9HDAC8
SCHEMBL13781089 0.78 L3MBTL1 (0.65) MEN1KMT2ASMN1; SMN2SRD5A2TDP1
SCHEMBL17284937 0.77 SRD5A2 (0.56) SIRT1MEN1KMT2ASMN1; SMN2SRD5A2
SCHEMBL26662921 0.77 ALDH1A1 (0.50) MEN1KMT2ASMN1; SMN2TDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206351-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-12-08 — — US disclosed
US-9206351-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-12-08 — — US disclosed
US-20090167166-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2009-07-02 — — US disclosed
US-20090167166-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090167166-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES PIEZO1, OR10J3, PUF60 SIRT1 3429/4885MEN1 405/4885KMT2A 3329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback